Transonic Systems

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Transonic Systems sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).

12 total trials none currently recruiting 9 completed top decile by trial count

Transonic Systems: 12 sponsored US clinical trials, none currently recruiting.

Transonic Systems sponsors 12 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 9 completed. The most-studied condition in this pipeline is Cardiac Output, with 1 trials.

Top-decile sponsor footprint

Transonic Systems ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 27/100

9 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

12 total, page 1 of 1

COMPLETED

Comparison of Cardiac Output Measured by Ultrasound Dilution Method and Pulmonary Artery Thermodilution Technique

NCT01616017
COMPLETED

Estimation of Cardiac Output in Neonatal ICU Using an Ultrasound Dilution Technique

NCT01610622
COMPLETED

Measurement of Cardiac Output and Intravascular Volume Status in Children Using COstatus (SH)

NCT01613859
COMPLETED

Study of Shunt Flow Sensor Accuracy in Extra-ventricular Drains.

NCT01108965
TERMINATED

Cardiac Output Measurement at the Conclusion of Cardiopulmonary Bypass

NCT01103908
COMPLETED

Monitoring Patient Cerebro-Spinal Fluid Drainage With an Ultrasonic Flow Sensor

NCT00652197
COMPLETED

Comparison of Techniques for Assessing Cardiac Output and Preload in Critically Ill Pediatric Patients

NCT00853437
COMPLETED

Validation of Minimally Invasive Ultrasound Indicator Dilution Technique in Critically Ill Children

NCT00852254
COMPLETED

Accurate Measurement of Cardiac Output Using the Ultrasound Dilution Technique

NCT00851422
TERMINATED

Measurement of Cardiac Output Before and After Cardiopulmonary Bypass.

NCT01103895
COMPLETED

Measurement of Recirculation During Venovenous Extracorporeal Membrane Oxygenation (VV ECMO)

NCT00920062
TERMINATED

Recirculation, Oxygenator Blood Volume and Cardiac Output Measurements During Extracorporeal Membrane Oxygenation

NCT00920569

Therapeutic Areas

Cardiac Output 1

How the Transonic Systems archive is shaped

12 indexed studies, none listed as recruiting (0% open); 9 completed (75%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Cardiac Output (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Transonic Systems: archived-pipeline peers nationwide

Peers matched on 12 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Transonic Systems sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%5%10%15%20% Total trials Recruiting share Transonic SystemsAlachua Government ServicesAllergy TherapeuticsAmpio Pharmaceuticals.Angiodynamics10xBio22nd Century Group23andMe3-C Institute for Social Development
Transonic Systems sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Transonic Systems sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 12 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Transonic Systems page

12 registered trials is a research-attention snapshot, not an endorsement of Transonic Systems or any single study.

  • None of Transonic Systems's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Cardiac Output is the condition Transonic Systems studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cardiac Output trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Transonic Systems pipeline card: 12 registered trials from official public datasets.Report a data error.